生物
免疫调节
免疫系统
核糖核酸
细胞生物学
细胞
调制(音乐)
计算生物学
免疫学
生物化学
基因
物理
声学
作者
Emily H. Kim,Sridatta V. Teerdhala,Marshall Scott Padilla,Ryann A. Joseph,Jacqueline J. Li,Rebecca M. Haley,Michael J. Mitchell
标识
DOI:10.1002/eji.202451008
摘要
Lipid nanoparticles (LNPs) have emerged as the preeminent nonviral drug delivery vehicles for nucleic acid therapeutics, as exemplified by their usage in the mRNA COVID-19 vaccines. As a safe and highly modular delivery platform, LNPs are attractive for a wide range of applications. In addition to vaccines, LNPs are being utilized as platforms for other immunoengineering efforts, especially as cancer immunotherapies by modulating immune cells and their functionality via nucleic acid delivery. In this review, we focus on the methods and applications of LNP-based immunotherapy in five cell types: T cells, NK cells, macrophages, stem cells, and dendritic cells. Each of these cell types has wide-reaching applications in immunotherapy but comes with unique challenges and delivery barriers. By combining knowledge of immunology and nanotechnology, LNPs can be developed for improved immune cell targeting and transfection, ultimately working toward novel clinical therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI